Human cell lines with neuronal and neuroendocrine features were examined for their expression of pp6OC-sr, the cellular homolog of the transforming gene product pp6vs-C of Rous sarcoma virus. Four neuroblastoma (LA-N-5, SH-SY5Y, Paju, and SK-N-MC) and three small-cell lung carcinoma (U-2020, U-1690, and The oncogene of Rous sarcoma virus (RSV) and its cellular homolog code for phosphoproteins, pp60v-src and pp60csr, respectively, which both have tyrosyl kinase activity (17, 18). The transforming capacity of the pp6Ov-src protein is dependent on its tyrosyl kinase activity (48). The specific kinase activity of the v-src protein appears to be higher than that of pp60-src (27). However, increased expression of c-src in cells that become transformed by v-src does not lead to transformation (28,30,42). Furthermore, low levels of v-src kinase activity are sufficient for transformation (29), indicating that there are other differences between the v-src and c-src proteins that are essential for the transformation process. However, the association of middle tumor antigen of polyomavirus and pp60c-src (21) activates the c-src kinase (14). This has been suggested as a necessary step for transformation by polyomavirus (22)